IL-15 controls T cell functions through its influence on CD30 and OX40 antigens in celiac disease

Cytokine

Volumn 67, Issue 1, 2014, Pages 44-51

  Periolo, N ^a   Guillen L ^a   Arruvito, M L ^a   Alegre, N S ^a   Niveloni, S I ^b   Hwang, J H ^b   Bai, J C ^b   Chernavsky A C ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

Author keywords

CD30; Celiac Disease; Interleukin 15; OX40; T cells

Indexed keywords

CD134 ANTIGEN; CD3 ANTIBODY; CD30 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 15; TRANSCRIPTION FACTOR FOXP3; CD3 ANTIGEN; IL15 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; OX40 LIGAND; RECOMBINANT PROTEIN; TNFSF4 PROTEIN, HUMAN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELL FUNCTION; CELL SURVIVAL; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUODENUM MUCOSA; EFFECTOR CELL; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; LAMINA PROPRIA; MALE; MEMORY T LYMPHOCYTE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOBLAST; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT; BIOSYNTHESIS; CYTOLOGY; DUODENUM; IMMUNOLOGY; INTESTINE MUCOSA; MUCOSA;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD30; CELIAC DISEASE; DUODENUM; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKIN-4; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MUCOUS MEMBRANE; OX40 LIGAND; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84896066685     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.01.004     Document Type: Article

References (38)

1. Maki M., Collin P. Coeliac disease. Lancet 1997, 349:1755-1759.
2. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
3. Di Sabatino A., Pickard K.M., Gordon J.N., Salvati V., Mazzarella G., Beattie R.M., et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007, 133:1175-1187.
4. Di Sabatino A., Ciccocioppo R., Cupelli F., Cinque B., Millimaggi D., Clarkson M.M., et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006, 55:469-477.
5. Leon A.J., Garrote J.A., Blanco-Quiros A., Calvo C., Fernandez-Salazar L., Del Villar A., et al. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin Exp Immunol 2006, 146:479-485.
6. Bernardo D., Garrote J.A., Fernandez-Salazar L., Riestra S., Arranz E. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides. Gut 2007, 56:889-890.
7. Bernardo D., Garrote J.A., Allegretti Y., Leon A., Gomez E., Bermejo-Martin J.F., et al. Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin Exp Immunol 2008, 154:64-73.
8. Ebert E.C. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 1998, 115:1439-1445.
9. Ebert E.C., Jabri B. Massive interleukin-12-induced interferon-gamma production by interleukin-15-stimulated lamina propria lymphocytes followed by down-regulation of the interleukin-12 receptor. Immunology 2008, 124:453-460.
10. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999, 162:4511-4520.
11. Benahmed M., Meresse B., Arnulf B., Barbe U., Mention J.J., Verkarre V., et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007, 132:994-1008.
12. DePaolo R.W., Abadie V., Tang F., Fehlner-Peach H., Hall J.A., Wang W., et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011, 471:220-224.
13. Lodolce J.P., Burkett P.R., Koka R.M., Boone D.L., Ma A. Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev 2002, 13:429-439.
14. Bulfone-Paus S., Durkop H., Paus R., Krause H., Pohl T., Onu A. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 1997, 9:507-513.
15. Kober J., Leitner J., Klauser C., Woitek R., Majdic O., Stockl J., et al. The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol 2008, 38:2678-2688.
16. Aggarwal B.B. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis. JNK NF-kappaB Ann Rheum Dis 2000, 59(Suppl. 1):i6-16.
17. Deshpande P., Cavanagh M.M., Le Saux S., Singh K., Weyand C.M., Goronzy J.J. IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J Immunol 2013, 190:1416-1423.
18. Sugamura K., Ishii N., Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 2004, 4:420-431.
19. Campbell D.J., Koch M.A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011, 11:119-130.
20. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992, 102:330-354.
21. Cabanne A., Vazquez H., Argonz J., Moreno M.L., Nachman F., Niveloni S., et al. Clinical utility of counting intraepithelial lymphocytes in celiac disease intestinal mucosa. Acta Gastroenterol Latinoam 2007, 37:20-28.
22. Sugai E., Selvaggio G., Vazquez H., Viola M., Mazure R., Pizarro B., et al. Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit. Am J Gastroenterol 2000, 95:2318-2322.
23. Olerup O., Aldener A., Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993, 41:119-134.
24. Corazza G.R., Biagi F., Volta U., Andreani M.L., De Franceschi L., Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997, 350:106-109.
25. Madrigal L., Lynch S., Feighery C., Weir D., Kelleher D., O'Farrelly C. Flow cytometric analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies. J Immunol Methods 1993, 158:207-214.
26. Ludvigsson J.F., Leffler D.A., Bai J.C., Biagi F., Fasano A., Green P.H., et al. The Oslo definitions for coeliac disease and related terms. Gut 2013, 62:43-52.
27. Taraban V.Y., Rowley T.F., O'Brien L., Chan H.T., Haswell L.E., Green M.H., et al. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Eur J Immunol 2002, 32:3617-3627.
28. Magg T., Mannert J., Ellwart J.W., Schmid I., Albert M.H. Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur J Immunol 2012, 42:1627-1638.
29. Periolo N., Guillen L., Bernardo D., Niveloni S.I., Hwang H.J., Garrote J.A., et al. Altered expression of the lymphocyte activation antigen CD30 in active celiac disease. Autoimmunity 2010, 43:288-298.
30. So T., Soroosh P., Eun S.Y., Altman A., Croft M. Antigen-independent signalosome of CARMA1, PKCtheta, and TNF receptor-associated factor 2 (TRAF2) determines NF-kappaB signaling in T cells. Proc Natl Acad Sci USA 2011, 108:2903-2908.
31. Zanzi D., Stefanile R., Santagata S., Iaffaldano L., Iaquinto G., Giardullo N., et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Am J Gastroenterol 2011, 106:1308-1317.
32. Hmida N.B., Ben Ahmed M., Moussa A., Rejeb M.B., Said Y., Kourda N., et al. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?. Am J Gastroenterol 2012, 107:604-611.
33. Vu M.D., Xiao X., Gao W., Degauque N., Chen M., Kroemer A., et al. OX40 costimulation turns off Foxp3+ Tregs. Blood 2007, 110:2501-2510.
34. Messi M., Giacchetto I., Nagata K., Lanzavecchia A., Natoli G., Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 2003, 4:78-86.
35. Iorio R., Frisullo G., Nociti V., Patanella K.A., Bianco A., Marti A., et al. T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. Clin Immunol 2009, 131:70-83.
36. Niedbala W., Wei X., Liew F.Y. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro. Eur J Immunol 2002, 32:341-347.
37. Tjon J.M., Verbeek W.H., Kooy-Winkelaar Y.M., Nguyen B.H., van der Slik A.R., Thompson A., et al. Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood 2008, 112:5103-5110.
38. Schmitz F., Tjon J.M., Lai Y., Thompson A., Kooy-Winkelaar Y., Lemmers R.J., et al. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut 2013, 62(4):509-519.